Pseudolarix Acid B, a New Tubulin-Binding Agent, Inhibits Angiogenesis by Interacting with a Novel Binding Site on Tubulin-Reference-Cited by-同舟云学术

Pseudolarix Acid B, a New Tubulin-Binding Agent, Inhibits Angiogenesis by Interacting with a Novel Binding Site on Tubulin

Published:2006-01-19 Issue:4 Volume:69 Page:1226-1233
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Tong Yun-Guang,Zhang Xiong-Wen,Geng Mei-Yu,Yue Jian-Ming,Xin Xian-Liang,Tian Fang,Shen Xu,Tong Lin-Jiang,Li Mei-Hong,Zhang Chao,Li Wei-Hong,Lin Li-Ping,Ding Jian

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference30 articles.

1. Inhibition of Endothelial Cell Migration, Intercellular Communication, and Vascular Tube Formation by Thromboxane A2

2. Promotion of Fluorescence upon Binding of Colchicine to Tubulin

3. The interaction of 1-anilino-8-naphthalene sulfonate with tubulin: A site independent of the colchicine-binding site

4. Small molecule inhibitors of receptor tyrosine kinases

5. Recombinant human erythropoietin stimulates angiogenesis in vitro

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, and evaluation of antitumor activity in Pseudolaric acid B Azole derivatives: Novel and potent angiogenesis inhibitor via regulation of the PI3K/AKT and MAPK mediated HIF-1/VEGF signaling pathway;European Journal of Medicinal Chemistry;2024-11

2. Pseudolaric Acid B Targets CD147 to Selectively Kill Acute Myeloid Leukemia Cells;International Journal of Molecular Sciences;2024-06-13

3. Laxiflorin B covalently binds the tubulin colchicine-binding site to inhibit triple negative breast cancer proliferation and induce apoptosis;Chemico-Biological Interactions;2023-09

4. Discovery of 6-aryl-2-(3,4,5-trimethoxyphenyl)thiazole[3,2-b][1,2,4]triazoles as potent tubulin polymerization inhibitors;European Journal of Medicinal Chemistry;2023-08

5. Discovery and biological evaluation of 4,6-pyrimidine analogues with potential anticancer agents as novel colchicine binding site inhibitors;European Journal of Medicinal Chemistry;2023-02